Loading company…
Riskpilot
← Back to search
Sign in
Get full access
Esrum Biotech ApS
APS
Active
CVR 43131761
Søparken 7
Engineering activities and related technical consultancy · NACE 7112
Est. 2022
1 employees
Watchlist
Share
Download PDF
Full Risika report
Overview
Financials
People & ownership
Related companies
Revenue 2025
DKK 247K
-86% vs 2024
EBITDA margin
51.4%
-92% vs 2024
Equity ratio
17.0%
Financial strength
Net profit 2025
DKK 96K
-92% vs 2024
EBITDA — year on year
DKK millions
3M
2M
1M
1M
0M
1M
2022
2M
+100%
2023
2M
0%
2024
0M
-100%
2025
Key figures
Annual report 2025
Revenue
DKK 247K
-86%
EBITDA
DKK 127K
-92%
Net profit
DKK 96K
-92%
Total assets
DKK 798K
-78%
Equity
DKK 136K
-96%
Employees
1
—
Company information
Legal name
Esrum Biotech ApS
CVR number
43131761
Legal form
Anpartsselskab
NACE code
7112 · Engineering activities and related technical consultancy
Founded
15. marts 2022
Share capital
DKK 40.000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør.
Company purpose
Selskabets formål er at udøve virksomhed med handel og service samt aktiviteter i tilknytning hertil.
Contact
Address
Søparken 7
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Engineering activities and related technical consultancy
Companies in Hillerød
All Denmark companies
Revenue
DKK millions
0M
1M
1M
2M
2M
1M
2022
2M
2023
2M
2024
0M
2025
EBITDA
DKK millions
0M
1M
1M
2M
2M
1M
2022
2M
2023
2M
2024
0M
2025
Income statement
DKK thousands
Item
2022
2023
2024
2025
Revenue
1.459
2.009
1.763
247
Staff expenses
-72
-126
-180
-120
EBITDA
1.387
1.883
1.583
127
Depreciation & amort.
-0
-0
-0
-0
EBIT
1.387
1.883
1.583
127
Net financials
-3
-11
-32
-3
Profit before tax
1.384
1.872
1.551
124
Tax
305
414
349
28
Net profit
1.079
1.458
1.202
96
Balance sheet
DKK thousands
Item
2022
2023
2024
2025
Total assets
1.383
3.044
3.638
798
Equity
1.119
2.387
3.589
136
Long-term debt
0
0
0
0
Short-term debt
263
657
49
662
Total debt
263
657
49
662
Financial ratios
5-year trend
EBITDA margin
51.4%
This company
15.8%
Market median
+225% vs market
2022
2025
Equity ratio
17.0%
This company
38.2%
Market median
-55% vs market
2022
2025
Return on equity
70.5%
This company
18.4%
Market median
+283% vs market
2022
2025
Net profit margin
38.8%
This company
8.1%
Market median
+379% vs market
2022
2025
Asset turnover
0.31×
This company
1.12×
Market median
-72% vs market
2022
2025
Debt / equity
4.88×
This company
0.62×
Market median
-687% vs market
2022
2025
Annual reports & filings
Annual report 2025
Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via CVR / Virk · Period 2022-03-15 – 2022-12-31
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Current (3)
ST
Søren Thye Agger
Founder
Founder
2022
MK
Mette Kirstine Agger
Management
Management
2022
NP
Nis Peter Agger
Founder
Founder
2022
Board of directors
Non-executive oversight
No data on file.
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Esrum Biotech Holding ApS
Company
100%
100%
2024
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
Esrum Biotech Holding ApS
Esrum Biotech ApS
(this company)
Board network connections
Board members of Esrum Biotech ApS also hold positions in
0
other companies.
Person
Role here
Other companies
Søren Thye Agger
Founder
0 companies
Mette Kirstine Agger
Management
0 companies
Nis Peter Agger
Founder
0 companies